Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE

INTRODUCTION: Achievement of remission is a key treatment goal for patients with axial spondyloarthritis (axSpA). C-OPTIMISE assessed achievement of sustained clinical remission in patients with axSpA, including radiographic (r) and non-radiographic (nr) axSpA, during certolizumab pegol (CZP) treatm...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Rheumatol Ther
Prif Awduron: Landewé, Robert, van der Heijde, Désirée, Dougados, Maxime, Baraliakos, Xenofon, Van den Bosch, Filip, Gaffney, Karl, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Thomas, Karen, Gensler, Lianne S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Healthcare 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410911/
https://ncbi.nlm.nih.gov/pubmed/32529495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00214-7
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg